Altimmune, Inc. (ALT) has 54 open-market insider trades by 20 insiders since 2006. Over the last six months insiders net bought $44K. The most active filer is Derace L. Schaffer, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| VHCP Management III, LLC | 10% Owner | — | 1 | $20.6M | 2021-02-25 |
| VHCP Co-Investment Holdings II, LLC | 10% Owner | — | 1 | $11.3M | 2020-06-15 |
| Velocity Pharmaceutical Holdings LLC | 10% Owner | — | 1 | $1.9M | 2020-05-15 |
| Derace L. Schaffer | Dir | — | 9 | $1.3M | 2017-12-29 |
| M. Scot Roberts | CSO | — | 4 | $962K | 2026-07-31 |
| Vipin K. Garg | CEOPres | — | 3 | $668K | 2026-01-31 |
| Wayne Pisano | Dir | — | 4 | $432K | 2026-01-08 |
| David Drutz | Dir | — | 6 | $296K | 2024-08-19 |
| John Gill | Dir | — | 5 | $279K | 2026-04-06 |
| Matthew Scott Harris | — | — | 2 | $268K | 2025-07-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jerome Benedict Durso | CEO & President | Buy | $44K | 2026-08-13 |
| John Gill | Director | Buy | $31K | 2026-04-06 |
| Gregory L. Weaver | CFO | Buy | $31K | 2026-04-01 |
| Jerome Benedict Durso | CEO & President | Buy | $47K | 2026-04-01 |
| Gregory L. Weaver | CFO | Buy | $18K | 2026-03-06 |
| Jerome Benedict Durso | President | Buy | $71K |
Companies that share insiders with ALT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-03-06 |
| Wayne Pisano | Director | Buy | $20K | 2026-01-08 |
| Catherine A. Sohn | Director | Buy | $2K | 2026-01-05 |
| Diane Jorkasky | Director | Buy | $2K | 2025-12-29 |
| John Gill | Director | Buy | $103K | 2025-12-23 |
| Jerome Benedict Durso | Director | Buy | $52K | 2025-12-22 |
| Catherine A. Sohn | Director | Buy | $6K | 2025-03-17 |
| Gregory L. Weaver | CFO | Buy | $52K | 2025-03-13 |
| David Drutz | Director | Sell | $221K | 2024-08-19 |
| David Drutz | Director | Buy | $864 | 2023-08-15 |